TORONTO - Canada has delayed the implementation of new drug price rules that had been due to go into effect on Friday by six months, the pharmaceutical industry’s main lobby group said on Wednesday.
“The middle of a global pandemic is not the time to implement measures that will distract from the fight against COVID-19,” said Innovative Medicines Canada , which represents major drugmakers in Canada. The rules are now set to go into effect on July 1, 2021, according to IMC. Health Canada did not immediately comment.